Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specialising in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced on Thursday that it has been honoured with multiple awards by Top Workplaces and the US News & World Report 2024-2025 ratings.
Top Workplaces has added Zynex to its 2024 Top Workplaces - Manufacturing list. US News & World Report has also offered Zynex with three awards under its 'Best Companies to Work For' in 2024-2025 ratings, including 'Best in Pharmaceuticals and Health Products', 'Best Companies' and 'Best in the West'.
Thomas Sandgaard, Founder, Chairman, and CEO of Zynex, said, 'We are privileged to be recognized by both Top Workplaces and US News & World Report, recognizing the emphasis we place on our team by developing leaders and sustaining employee well-being. We continue to place a high priority on supporting our employees to advance in their careers and maintain work/life balances. By improving on our team's health, benefits and comfort, we can in turn empower them to accelerate progress on business goals including order growth, FDA approvals of next-generation devices, and new therapy products.'
PTC Therapeutics to sell Priority Review Voucher for USD150m
Novartis' Kisqali approved in EU for broader population of high-risk early breast cancer patients
Merck reports positive Phase 3 ZENITH results for WINREVAIR in PAH treatment
Alnylam's sNDA for vutrisiran accepted by FDA; PDUFA date set for March 2025
GSK plc announces US FDA acceptance of review for Blenrep combinations in multiple myeloma
Hanmi Pharmaceutical and Beijing Hanmi Pharmaceutical announce progress in BH3120 clinical trial
Johnson & Johnson seeks FDA approval for subcutaneous TREMFYA
BioLineRx signs licence agreement with Ayrmid
Benuvia Operations signs licensing and supply agreements with Medra Brasil Medicamentos